Comparison between the clinical effect of propofol plus etomidate (EP) alone and fentanyl or sufentanil in balanced EP sedation for colonoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010907

Enrollment

Unknown

Registered

2017-03-18

Start date

2017-03-16

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Sedation

Interventions

C:Normal Saline

F group:fentanyl

S group:sufentanil

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients were considered eligible to participate if they were 20 years to 65 years and scheduled for colonoscopy.

Exclusion criteria

Exclusion criteria: Exclusion criteria were hypersensitivity to propofol, fat milk, soybeans, or eggs; ASA risk class 3 or higher; serious heart, lung, liver and kidney dysfunction; obstructive sleep apnea-hypopnea syndrome(OSAHS); body mass =28kg/m2; difficult intubation; history of drug or alcohol abuse; refuse to participate in the study; and pregnancy.

Design outcomes

Primary

Measure	Time frame
The Number of Body Movement;Recovery Time;Pain Score;vital signs;adverse effects;	—

Countries

China

Contacts

Public ContactGuangjun Hu

Department of Anesthesiology, Wuhan General Hospital of the Chinese PLA

jeanhu@163.com+86 18907132861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026